YAP1 and breast carcinoma: The YAP/TAZ-driven feedback loop, mediated by miR-10b-3p, amplifies SPAG5 expression, highlighting YAP/TAZ or SPAG5 as potential therapeutic targets in breast cancer (Canu et al., 2021[11]).